Publications/Patents (recent)
Liu Y. #, Zhan Y., Chen Z., He A., Li J., Wu H., Liu L., Zhuang C., Lin J., Guo X., Zhang Q., Huang W. *, Cai Z. *. Directing cellular information flow via CRISPR signal conductors.Nature Methods,2016;13 (11):938. (IF:32.072)
Liu Y#, Zeng Y, Liu L, Zhuang C, Fu X, Huang W*, Cai Z*. Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells. Nat Commun., 2014 Nov 6;5:5393. (IF:12.123)
Zhan H. #; Zhou Q. #; Gao Q.#; Li J. #, Huang W. *, Liu Y. *. Multiplexed promoterless gene expression with CRISPReader. Genome Biology.2019,20:113. (IF:14.028)
Zhan H#, Xie H#, Zhou Q#, Liu Y*, HuangW*.Synthesizing a Genetic Sensor Based on CRISPR-Cas9 for Specifically Killing p53-Deficient Cancer Cells. ACS Synth Biol. 2018 Jul 20;7(7):1798-1807. (IF:5.316)
Lin Z. #, Wang M., He S., Cai Z. *, Huang W. *.TACC3 transcriptionally 1 upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.Cell Death & Disease, 2018 Jan 22; 9(2):72.(IF:6.375)